Once your doctor prescribes CanAssist Breast, the hospital laboratory will send your tumor sample (FFPE block) to OncoStem’s laboratory for analysis. Our experts perform the test and share the detailed risk report with your doctor within 8 business days.
This streamlined process ensures timely and personalized treatment decisions for early-stage breast cancer patients.